stockrowOpus Genetics, Inc. (IRD) vs ProKidney Corp. (PROK)
- Opus Genetics, Inc. IRD 4.17 +3.99%
- ProKidney Corp. PROK 1.15 +7.48%
Opus Genetics, Inc. and ProKidney Corp. are both Biotechnology companies. Opus Genetics, Inc. and ProKidney Corp. are of similar size ($333.2M and $322.0M). Opus Genetics, Inc. has the higher net margin (−1,091.8% vs −10,288.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Opus Genetics, Inc. leads on 11 and ProKidney Corp. on 2.
Valuation
Profitability
| Metric | IRD | PROK | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | (513.47%) | (21,664.55%) | 0.00% |
| Net margin | (1,091.82%) | (10,288.39%) | 0.00% |
| Free cash flow margin | (412.61%) | (17,300.61%) | 0.00% |
| Return on equity | (4,796.52%) | 8.92% | (51.96%) |
| Return on assets | (163.50%) | (27.10%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack